Gyon Technologies Capital Management, LP Astrazeneca PLC Transaction History

Gyon Technologies Capital Management, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$54.21 - $70.44 $1.7 Million - $2.2 Million	-31,296 Reduced 62.72%	18,598 $1.26 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $1.5 Million - $3.84 Million	28,322 Added 131.29%	49,894 $2.74 Million
Q2 2022 Aug 15, 2022	BUY	$59.26 - $71.14 $415,886 - $499,260	7,018 Added 48.22%	21,572 $1.43 Million
Q1 2022 May 12, 2022	SELL	$55.72 - $67.12 $143,479 - $172,834	-2,575 Reduced 15.03%	14,554 $966,000
Q4 2021 Feb 11, 2022	SELL	$54.02 - $63.83 $2.8 Million - $3.31 Million	-51,803 Reduced 75.15%	17,129 $998,000
Q3 2021 Nov 18, 2021	BUY	$55.56 - $60.79 $3.83 Million - $4.19 Million	68,932 New	68,932 $4.14 Million
Q2 2021 Aug 16, 2021	SELL	$48.42 - $60.18 $278,802 - $346,516	-5,758 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$47.16 - $54.44 $1.06 Million - $1.22 Million	-22,486 Reduced 79.61%	5,758 $286,000
Q4 2020 Feb 16, 2021	BUY	$48.52 - $58.02 $1.37 Million - $1.64 Million	28,244 New	28,244 $1.41 Million

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.